Found: 86
Select item for more details and to access through your institution.
Gender, clamped hyperglycemia and arterial stiffness in patients with uncomplicated type 1 diabetes mellitus.
- Published in:
- Clinical & Experimental Hypertension, 2014, v. 36, n. 3, p. 187, doi. 10.3109/10641963.2013.804543
- By:
- Publication type:
- Article
Risk factors for diabetic kidney disease in adults with longstanding type 1 diabetes: results from the Canadian Study of Longevity in Diabetes.
- Published in:
- Renal Failure, 2019, v. 41, n. 1, p. 427, doi. 10.1080/0886022X.2019.1614057
- By:
- Publication type:
- Article
Proximal versus distal diuretics in congestive heart failure.
- Published in:
- Nephrology Dialysis Transplantation, 2024, v. 39, n. 9, p. 1392, doi. 10.1093/ndt/gfae058
- By:
- Publication type:
- Article
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics.
- Published in:
- Nephrology Dialysis Transplantation, 2020, v. 35, n. 10, p. 1700, doi. 10.1093/ndt/gfaa234
- By:
- Publication type:
- Article
The impact of empagliflozin on kidney injury molecule-1: a subanalysis of the Effects of Empagliflozin on Cardiac Structure, Function, and Circulating Biomarkers in Patients with Type 2 Diabetes CardioLink-6 trial.
- Published in:
- Nephrology Dialysis Transplantation, 2020, v. 35, n. 5, p. 895, doi. 10.1093/ndt/gfz294
- By:
- Publication type:
- Article
Plasma biomarkers improve prediction of diabetic kidney disease in adults with type 1 diabetes over a 12-year follow-up: CACTI study.
- Published in:
- Nephrology Dialysis Transplantation, 2018, v. 33, n. 7, p. 1189, doi. 10.1093/ndt/gfx255
- By:
- Publication type:
- Article
Management of Type 2 Diabetic Kidney Disease in 2022: A Narrative Review for Specialists and Primary Care.
- Published in:
- Canadian Journal of Kidney Health & Disease, 2023, p. 1, doi. 10.1177/20543581221150556
- By:
- Publication type:
- Article
Management of Type 2 Diabetic Kidney Disease in 2022: A Narrative Review for Specialists and Primary Care.
- Published in:
- Canadian Journal of Kidney Health & Disease, 2023, v. 10, p. 1, doi. 10.1177/20543581221150556
- By:
- Publication type:
- Article
SGLT2 Inhibition in Patients With Type 2 Diabetes Mellitus Post-Nephrectomy: A Single-Center Case Series.
- Published in:
- Canadian Journal of Kidney Health & Disease, 2021, p. 1, doi. 10.1177/20543581211065528
- By:
- Publication type:
- Article
SGLT2 Inhibition in Patients With Type 2 Diabetes Mellitus Post-Nephrectomy: A Single-Center Case Series.
- Published in:
- Canadian Journal of Kidney Health & Disease, 2021, p. 1, doi. 10.1177/20543581211065528
- By:
- Publication type:
- Article
Ertugliflozin and hospitalization for heart failure across the spectrum of pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial.
- Published in:
- European Heart Journal, 2023, v. 44, n. 48, p. 5163, doi. 10.1093/eurheartj/ehad639
- By:
- Publication type:
- Article
The New Biology of Diabetic Kidney Disease—Mechanisms and Therapeutic Implications.
- Published in:
- Endocrine Reviews, 2020, v. 41, n. 2, p. 202, doi. 10.1210/endrev/bnz010
- By:
- Publication type:
- Article
Effects of ertugliflozin on uric acid and gout‐related outcomes in persons with type 2 diabetes and cardiovascular disease: Post hoc analyses from VERTIS CV.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5336, doi. 10.1111/dom.15895
- By:
- Publication type:
- Article
Hypoglycaemia and kidney events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 8, p. 3478, doi. 10.1111/dom.15687
- By:
- Publication type:
- Article
An update review of post‐transplant diabetes mellitus: Concept, risk factors, clinical implications and management.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 7, p. 2531, doi. 10.1111/dom.15575
- By:
- Publication type:
- Article
Effect of sotagliflozin on albuminuria in patients with type 2 diabetes and chronic kidney disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3410, doi. 10.1111/dom.15203
- By:
- Publication type:
- Article
Safety, tolerability, pharmacodynamics and pharmacokinetics of the soluble guanylyl cyclase activator BI 685509 in patients with diabetic kidney disease: A randomized trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2218, doi. 10.1111/dom.15099
- By:
- Publication type:
- Article
Efficacy and safety of sotagliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1646, doi. 10.1111/dom.15019
- By:
- Publication type:
- Article
Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1398, doi. 10.1111/dom.14965
- By:
- Publication type:
- Article
Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 9, p. 1829, doi. 10.1111/dom.14769
- By:
- Publication type:
- Article
Effects of dapagliflozin on volume status and systemic haemodynamics in patients with chronic kidney disease without diabetes: Results from DAPASALT and DIAMOND.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 8, p. 1578, doi. 10.1111/dom.14729
- By:
- Publication type:
- Article
Evaluation of the Pharmacokinetics and Exposure–Response Relationship of Dapagliflozin in Patients without Diabetes and with Chronic Kidney Disease.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 4, p. 517, doi. 10.1007/s40262-020-00956-1
- By:
- Publication type:
- Article
Cardiorenal outcomes with ertugliflozin assessed according to baseline glucose‐lowering agent: An analysis from VERTIS CV.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1245, doi. 10.1111/dom.14691
- By:
- Publication type:
- Article
The differential effects of ertugliflozin on glucosuria and natriuresis biomarkers: Prespecified analyses from VERTIS CV.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 6, p. 1114, doi. 10.1111/dom.14677
- By:
- Publication type:
- Article
Efficacy and safety of sotagliflozin in patients with type 2 diabetes and severe renal impairment.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 12, p. 2632, doi. 10.1111/dom.14513
- By:
- Publication type:
- Article
Changes in plasma and urine metabolites associated with empagliflozin in patients with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 11, p. 2466, doi. 10.1111/dom.14489
- By:
- Publication type:
- Article
Renal hyperfiltration defined by high estimated glomerular filtration rate: A risk factor for cardiovascular disease and mortality.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2368, doi. 10.1111/dom.13831
- By:
- Publication type:
- Article
Association between uric acid, renal haemodynamics and arterial stiffness over the natural history of type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1388, doi. 10.1111/dom.13665
- By:
- Publication type:
- Article
Sodium glucose cotransporter (SGLT)‐2 inhibitors: Do we need them for glucose‐lowering, for cardiorenal protection or both?
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, p. 24, doi. 10.1111/dom.13692
- By:
- Publication type:
- Article
The relationships between markers of tubular injury and intrarenal haemodynamic function in adults with and without type 1 diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 575, doi. 10.1111/dom.13556
- By:
- Publication type:
- Article
Mycophenolate mofetil causing deep venous thrombosis in a renal transplant patient with factor V Leiden.
- Published in:
- Nephrology Dialysis Transplantation, 2001, v. 16, n. 8, p. 1702, doi. 10.1093/ndt/16.8.1702
- By:
- Publication type:
- Article
SGLT-2 inhibitors in nephrotic-range proteinuria: emerging clinical evidence.
- Published in:
- Clinical Kidney Journal, 2023, v. 16, n. 1, p. 52, doi. 10.1093/ckj/sfac189
- By:
- Publication type:
- Article
Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 Diabetes.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0141085
- By:
- Publication type:
- Article
The Urinary Cytokine/Chemokine Signature of Renal Hyperfiltration in Adolescents with Type 1 Diabetes.
- Published in:
- PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0111131
- By:
- Publication type:
- Article
Renal Hyperfiltration and Systemic Blood Pressure in Patients with Uncomplicated Type 1 Diabetes Mellitus.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0068908
- By:
- Publication type:
- Article
FINE-CKD Model to Evaluate Economic Value of Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes.
- Published in:
- American Journal of Managed Care, 2021, v. 27, p. S375, doi. 10.37765/ajmc.2021.88808
- By:
- Publication type:
- Article
Renal and Vascular Effects of Uric Acid Lowering in Normouricemic Patients With Uncomplicated Type 1 Diabetes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The Effect of Cyclooxygenase-2 Inhibition on Renal Hemodynamic Function in Humans With Type 1 Diabetes.
- Published in:
- Diabetes, 2008, v. 57, n. 3, p. 688, doi. 10.2337/db07-1230
- By:
- Publication type:
- Article
Impact of Cardio-Renal-Metabolic Comorbidities on Cardiovascular Outcomes and Mortality in Type 2 Diabetes Mellitus.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Ertugliflozin Delays Insulin Initiation and Reduces Insulin Dose Requirements in Patients With Type 2 Diabetes: Analyses From VERTIS CV.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 8, p. 2042, doi. 10.1210/clinem/dgac764
- By:
- Publication type:
- Article
Antidiuretic Hormone and Serum Osmolarity Physiology and Related Outcomes: What Is Old, What Is New, and What Is Unknown?
- Published in:
- 2019
- By:
- Publication type:
- journal article
SGLT2 Inhibition in Type 1 Diabetes with Diabetic Kidney Disease: Potential Cardiorenal Benefits Can Outweigh Preventable Risk of Diabetic Ketoacidosis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Retinopathy and RAAS Activation: Results From the Canadian Study of Longevity in Type 1 Diabetes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Serum Uromodulin Predicts Less Coronary Artery Calcification and Diabetic Kidney Disease Over 12 Years in Adults With Type 1 Diabetes: The CACTI Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Atherosclerosis and Microvascular Complications: Results From the Canadian Study of Longevity in Type 1 Diabetes.
- Published in:
- Diabetes Care, 2018, v. 41, n. 12, p. 2570, doi. 10.2337/dc18-1236
- By:
- Publication type:
- Article
Atherosclerosis and Microvascular Complications: Results From the Canadian Study of Longevity in Type 1 Diabetes.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Acute Effect of Empagliflozin on Fractional Excretion of Sodium and eGFR in Youth With Type 2 Diabetes.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Adiposity Impacts Intrarenal Hemodynamic Function in Adults With Long-standing Type 1 Diabetes With and Without Diabetic Nephropathy: Results From the Canadian Study of Longevity in Type 1 Diabetes.
- Published in:
- Diabetes Care, 2018, v. 41, n. 4, p. 831, doi. 10.2337/dc17-2475
- By:
- Publication type:
- Article
RESPONSE TO COMMENT ON LOVSHIN ET AL. Dipeptidyl Peptidase 4 Inhibition Stimulates Distal Tubular Natriuresis and Increases in Circulating SDF-1α<sup>1-67</sup> in Patients With Type 2 Diabetes. Diabetes Care 2017;40:1073-1081.
- Published in:
- Diabetes Care, 2017, v. 40, n. 11, p. e159, doi. 10.2337/dci17-0033
- By:
- Publication type:
- Article
Erratum. Dipeptidyl Peptidase 4 Inhibition Stimulates Distal Tubular Natriuresis and Increases in Circulating SDF-1α<sup>1-67</sup> in Patients With Type 2 Diabetes. Diabetes Care 2017;40:1073-1081.
- Published in:
- 2017
- By:
- Publication type:
- journal article